Claude Lemieux’s family announced that his brain will be given to Boston University’s CTE Center to investigate the lasting impact of repetitive brain injuries. Lemieux, who passed away at the age of 60 in an apparent suicide, had recently participated in a ceremonial role for the Montreal Canadiens. Over his career spanning from 1983 to 2009, Lemieux played in close to 1,500 NHL games for six different teams, known for his physical style of play and clutch performances leading to four Stanley Cup victories.
The family granted permission for the CTE Center to share any findings related to Lemieux’s case while emphasizing that no definitive conclusions should be made regarding any specific diagnosis. They highlighted Lemieux’s commitment to aiding future generations, transitioning to a career as an agent after retiring from professional hockey.
CTE, a degenerative brain condition resulting from repeated head trauma, has been found in the brains of several NHL players, including Bobby Hull, Henri Richard, Chris Simon, Bob Probert, and Steve Montador. Dr. Charles Tator, a prominent figure in concussion research, described CTE as a tragic condition often associated with depression and various symptoms that can only be confirmed posthumously.
Dr. Tator emphasized the importance of prevention since there is currently no known cure for CTE. While helmets can mitigate certain brain injuries, they do not prevent concussions or CTE, necessitating a more proactive approach to safeguarding players from head impacts in hockey.
The decision to study Lemieux’s brain aims to contribute to a deeper understanding of CTE, fostering open dialogue about mental health in sports and advocating for improved safety measures in athletics.